Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

Clinical trial NCT05686642 · RECRUITING

Trial details

NCT number: NCT05686642
Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2023-04-06
Primary completion: 2026-12-10
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.